IRS - Sydvestjysk Sygehus, Forskningsenhed for Klinisk Mikrobiologi (Esbjerg)

Medicin og biovidenskab

1. Denmark 100%
2. SARS Virus 39%
3. Microbiology 28%
4. Echinocandins 27%
5. Whole Genome Sequencing 26%
6. Infections 24%
7. Blood Culture 23%
8. Clone Cells 23%
9. Bacteremia 22%
10. carbapenemase 21%
11. Cohort Studies 20%
12. Candida glabrata 20%
13. Candidemia 20%
14. Mortality 19%
15. Genome 18%
16. Polymerase Chain Reaction 17%
17. Incidence 17%
18. Azoles 17%
19. Pseudomonas aeruginosa 16%
20. Endocarditis 16%
21. Klebsiella pneumoniae 16%
22. Registries 15%
23. Candida albicans 15%
24. Serum Albumin 14%
25. Anti-Bacterial Agents 14%
26. Staphylococcus aureus 14%
27. Observational Studies 14%
28. Severe Acute Respiratory Syndrome 14%
29. Coronavirus 13%
30. Streptococcus 13%
31. ocrelizumab 12%
32. C-Reactive Protein 12%
33. Escherichia coli 11%
34. Sepsis 11%
35. Population 11%
36. Epidemiological Monitoring 10%
37. Pandemics 10%
38. AmpC beta-lactamases 10%
39. Fungemia 10%
40. Sentinel Surveillance 10%
41. Onions 10%
42. Gastroenteritis 9%
43. Delivery of Health Care 9%
44. Enterococcus faecium 9%
45. Streptococcal Infections 9%
46. Vancomycin-Resistant Enterococci 9%
47. Community Health Services 9%
48. Disease Outbreaks 9%
49. Anaerobic Bacteria 8%
50. Health Care Sector 8%
51. Aspergillus fumigatus 8%
52. Streptococcus pyogenes 8%
53. Acinetobacter baumannii 8%
54. Pneumonia 8%
55. Methicillin 8%
56. Meningitis 8%
57. Guidelines 8%
58. Bronchiectasis 8%
59. Vancomycin 8%
60. Lymphoma, Large B-Cell, Diffuse 8%
61. Seroepidemiologic Studies 8%
62. Human Herpesvirus 1 8%
63. Vaccination 8%
64. Hydrogels 7%
65. Phagocytes 7%
66. Bacteria 7%
67. Biofilms 7%
68. Communicable Diseases 7%
69. Viral Load 7%
70. Acute Myeloid Leukemia 6%
71. Routine Diagnostic Tests 6%
72. Epidemiology 6%
73. Vaccines 6%
74. Simplexvirus 6%
75. Therapeutics 6%
76. Lung Diseases 6%
77. Chronic Obstructive Pulmonary Disease 6%
78. Public Health 6%
79. Multiple Sclerosis 6%
80. Health Personnel 6%
81. Albumins 6%
82. Confidence Intervals 6%
83. Epidemiologic Studies 6%
84. Coronary Artery Disease 6%
85. Computational Biology 6%
86. Tuberculosis 6%
87. Hospitalization 5%
88. China 5%
89. Candida 5%
90. Colorectal Neoplasms 5%
91. Recurrence 5%
92. Asthma 5%
93. Demography 5%
94. Joints 5%
95. Type 2 Diabetes Mellitus 5%
96. Antibodies 5%
97. Pseudomonas Infections 5%
98. Sensitivity and Specificity 5%
99. Fibrosis 5%
100. Chronic Disease 5%